Vaxfab Enterprises Intrinsic Value
Vaxfab Enterprises intrinsic value. Vaxfab Enterprises (VEL) median intrinsic value is ₹19.43 from 2 valuation models (range ₹13–₹19), vs current price ₹64.76 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Compare with VEL fair price to assess whether the stock is under or overvalued.
VEL Valuation Methods Summary — DCF, Graham Number & P/E
Vaxfab Enterprises intrinsic value across 2 models vs current price ₹64.76 — upside/downside and value range per method. For current market price and key ratios, visit VEL share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹12.95 | ₹11.65 - ₹14.25 | -80.0% | Book Value/Share: ₹11.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹19.43 | ₹17.49 - ₹21.37 | -70.0% | Revenue/Share: ₹12.00, P/S: 0.8x |
VEL Intrinsic Value vs Market Price — All Valuation Models
Vaxfab Enterprises fair value range ₹13–₹19 vs current market price ₹64.76 across 2 valuation models. Read VEL dividend growth for the complete payout history and dividend yield track record.
VEL Intrinsic Value Analysis — Undervalued or Overvalued?
Vaxfab Enterprises median intrinsic value ₹19.43, current price ₹64.76 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of VEL?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Vaxfab Enterprises (VEL) is ₹19.43 (median value). With the current market price of ₹64.76, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹12.95 to ₹19.43, indicating ₹12.95 - ₹19.43.
Is VEL undervalued or overvalued?
Based on our multi-method analysis, Vaxfab Enterprises (VEL) appears to be trading above calculated value by approximately 70.0%.
VEL Financial Health — Key Ratios vs Industry Benchmarks
Vaxfab Enterprises financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 168.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -27.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.24x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
VEL Cash Flow Quality — Operating & Free Cash Flow
Vaxfab Enterprises operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2023 | ₹2 Cr | ₹-4 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |